Oncology
2 drugs are in development for Small-cell Lung Cancer.
- Companies
- 1
- Clinical trials
- 16
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Small-cell Lung Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| IDE161 | IDEAYA Biosciences, Inc. (IDYA) |
About this indication
Small-cell Lung Cancer context
Oncology·MeSH: Small Cell Lung Carcinoma (D055752)
Also known as: Carcinoma, Small Cell Lung, Oat Cell Carcinoma of Lung, Oat Cell Lung Cancer, Small Cell Cancer Of The Lung
Compare drugs
Frequently asked questions
How many drugs are in development for Small-cell Lung Cancer?
BioSniper tracks 2 drugs in development for Small-cell Lung Cancer across 1 company.
How many clinical trials target Small-cell Lung Cancer?
There are 16 clinical trials targeting Small-cell Lung Cancer tracked by BioSniper.